The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 06-30-2024
Check here if Amendment    Amendment Number:
This Amendment (Check only one.):    is a restatement.
   adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: JOHNSON & JOHNSON
Address: One Johnson & Johnson Plz
New Brunswick, NJ  08933
Form 13F File Number: 028-20072

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Marc Larkins
Title: Secretary
Phone: 732-524-1476
Signature, Place, and Date of Signing:
/s/ Marc Larkins New BrunswickNJ 08-09-2024
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
   13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
   13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 1
Form 13F Information Table Entry Total: 20
Form 13F Information Table Value Total: 400,670,584
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name
1 028-20073 Johnson & Johnson Innovation - JJDC, Inc.

SEC FORM 13-F Information Table

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adicet Bio, Inc. COM 007002108 441,011 364,472 SH   DFND 1 0 364,472 0
Aldeyra Therapeutics, Inc. COM 01438T106 991,904 299,669 SH   DFND 1 0 299,669 0
Arrowhead Pharmaceuticals, Inc. COM 04280A100 6,435,072 247,598 SH   DFND 1 0 247,598 0
BiomX Inc. COM 09090D103 646,388 1,923,201 SH   DFND 1 0 1,923,201 0
Contineum Therapeutics Inc. CL A 21217B100 34,853,237 1,979,173 SH   DFND 1 0 1,979,173 0
CVRx, Inc. COM 126638105 49,200,126 4,103,430 SH   DFND 1 0 4,103,430 0
Fate Therapeutics, Inc. COM 31189P102 11,083,330 3,379,064 SH   DFND 1 0 3,379,064 0
Legend Biotech Corporation SPONSORED ADS 52490G102 36,078,014 814,586 SH   DFND 1 0 814,586 0
MeiraGTx Holdings plc COM G59665102 27,958,879 6,641,064 SH   DFND 1 0 6,641,064 0
Nano-X Imaging Ltd. ORD SHS M70700105 1,165,974 158,852 SH   DFND 1 0 158,852 0
Nanobiotix S.A. SPONSORED ADS 63009J107 28,119,080 5,623,816 SH   DFND 1 0 5,623,816 0
Neumora Therapeutics, Inc. COM 640979100 18,180,044 1,849,445 SH   DFND 1 0 1,849,445 0
Procept BioRobotics Corporation COM 74276L105 21,866,494 357,939 SH   DFND 1 0 357,939 0
Protagonist Therapeutics Inc. COM 74366E102 84,864,191 2,449,183 SH   DFND 1 0 2,449,183 0
Rallybio Corporation COM 75120L100 4,872,726 3,636,363 SH   DFND 1 0 3,636,363 0
Rapport Therapeutics, Inc. COM 75383L102 58,104,666 2,498,051 SH   DFND 1 0 2,498,051 0
Senseonics Holdings, Inc. COM 81727U105 21,794 54,621 SH   DFND 1 0 54,621 0
Vor Biopharma, Inc. COM 929033108 1,074,658 1,074,658 SH   DFND 1 0 1,074,658 0
Xencor, Inc. COM 98401F105 14,160,814 748,062 SH   DFND 1 0 748,062 0
Standard BioTools Inc COM 34385P108 552,182 311,967 SH   DFND   0 311,967 0